Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wing Leung

Showing results (381-390 of 415) with videos related to

Pageof 42
Sort By:
Aging Cell|October 27, 2023
A comprehensive AI-driven analysis of large-scale omic datasets reveals novel dual-purpose targets for the treatment of cancer and agingFrank W Pun, Geoffrey Ho Duen Leung, Hoi Wing Leung, et al.
Journal of Hepatology|June 26, 2017
Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiationMark Kin Fai Ma, Eunice Yuen Ting Lau, Doris Hoi Wing Leung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2017
A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory NeuroblastomaSara M Federico, M Beth McCarville, Barry L Shulkin, et al.
Pediatric Blood & Cancer|April 29, 2024
Autologous hematopoietic stem cell transplantation followed by quadruple immunotherapy with dinutuximab beta, sargramostim, aldesleukin, and spironolactone for relapsed metastatic retinoblastomaWilson Y K Chan, Ng Wai Fu, Eric C H Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2012
Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumorsFariba Navid, Sharyn D Baker, M Beth McCarville, et al.
Blood|April 21, 2012
Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemiaWing Leung, Ching-Hon Pui, Elaine Coustan-Smith, et al.
Blood|November 18, 2020
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantationMuna Qayed, Kwang Woo Ahn, Carrie L Kitko, et al.
Cancer Letters|June 22, 2020
Corrigendum to "NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma" [Canc. Lett. 476 (2020) 48-56]Hoi Wing Leung, Eunice Yuen Ting Lau, Carmen Oi Ning Leung, et al.
Journal of the American Chemical Society|July 9, 2024
Ligand-Receptor Interaction-Induced Intracellular Phase Separation: A Global Disruption Strategy for Resistance-Free Lethality of Pathogenic BacteriaAnming Yang, Junfeng Song, Jiaqi Li, et al.
Cancer Letters|February 17, 2020
NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinomaHoi Wing Leung, Eunice Yuen Ting Lau, Carmen Oi Ning Leung, et al.
Pageof 42

Showing results (381-390 of 415) with videos related to

Sort By:
Pageof 42
Aging Cell|October 27, 2023
A comprehensive AI-driven analysis of large-scale omic datasets reveals novel dual-purpose targets for the treatment of cancer and agingFrank W Pun, Geoffrey Ho Duen Leung, Hoi Wing Leung, et al.
Journal of Hepatology|June 26, 2017
Stearoyl-CoA desaturase regulates sorafenib resistance via modulation of ER stress-induced differentiationMark Kin Fai Ma, Eunice Yuen Ting Lau, Doris Hoi Wing Leung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2017
A Pilot Trial of Humanized Anti-GD2 Monoclonal Antibody (hu14.18K322A) with Chemotherapy and Natural Killer Cells in Children with Recurrent/Refractory NeuroblastomaSara M Federico, M Beth McCarville, Barry L Shulkin, et al.
Pediatric Blood & Cancer|April 29, 2024
Autologous hematopoietic stem cell transplantation followed by quadruple immunotherapy with dinutuximab beta, sargramostim, aldesleukin, and spironolactone for relapsed metastatic retinoblastomaWilson Y K Chan, Ng Wai Fu, Eric C H Fu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2012
Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumorsFariba Navid, Sharyn D Baker, M Beth McCarville, et al.
Blood|April 21, 2012
Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemiaWing Leung, Ching-Hon Pui, Elaine Coustan-Smith, et al.
Blood|November 18, 2020
A validated pediatric disease risk index for allogeneic hematopoietic cell transplantationMuna Qayed, Kwang Woo Ahn, Carrie L Kitko, et al.
Cancer Letters|June 22, 2020
Corrigendum to "NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinoma" [Canc. Lett. 476 (2020) 48-56]Hoi Wing Leung, Eunice Yuen Ting Lau, Carmen Oi Ning Leung, et al.
Journal of the American Chemical Society|July 9, 2024
Ligand-Receptor Interaction-Induced Intracellular Phase Separation: A Global Disruption Strategy for Resistance-Free Lethality of Pathogenic BacteriaAnming Yang, Junfeng Song, Jiaqi Li, et al.
Cancer Letters|February 17, 2020
NRF2/SHH signaling cascade promotes tumor-initiating cell lineage and drug resistance in hepatocellular carcinomaHoi Wing Leung, Eunice Yuen Ting Lau, Carmen Oi Ning Leung, et al.
Pageof 42